Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Clinical Outcomes of Two-session Catheter-directed Sclerotherapy Using Ethanol for Endometrioma

NCT06274086 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT06274086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06274086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Clinical Outcomes of Two-session Catheter-directed Sclerotherapy Using Ethanol for Endometrioma
Lead sponsor
Asan Medical Center
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2020
Completion date
March 31, 2023
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrioma, sclerotherapy